Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis

碳纳米管诱导纤维化的预测及机制

基本信息

  • 批准号:
    7983999
  • 负责人:
  • 金额:
    $ 36.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-15 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Project Summary: Environmental and occupational exposures to manufactured nanomaterials have markedly increased during the past recent years, and in all likelihood this trend will continue as new nanomaterials are being increasingly produced and used by various industries. This trend has been of great concern as the adverse health effects of nanomaterials are relatively unknown and understudied. Recent studies have shown that pulmonary exposure to carbon nanotubes (CNT), one of the most widely used nanomaterials in industry, results in rapid and progressive interstitial lung fibrosis in animals without causing persistent lung inflammation, which is normally associated with other known fibrogenic agents. This unusual fibrogenic effect of CNT raises important health issues since the exposure could result in deadly and incurable lung fibrosis. We hypothesize that CNT, due to their unique properties such as exceptionally small size, large aspect ratio, and chemical composition can rapidly enter the lung, penetrate the alveolar epithelial barrier, and interact with specific lung cells such as interstitial lung fibroblasts to induce fibroproliferation and extracellular matrix accumulation, which are characteristics of lung fibrosis. We also propose that such induction is mediated by signaling cascades that involve phosphatidylinositol-3-kinase(PI3K)/Akt activation and redox regulation of the profibrogenic and angiogenic factors such as TGF-b and VEGF. In Aim 1, we will determine the impact of certain nanoparticle characteristics (e.g., diameter, aspect ratio, dispersion status, and chemistry) on CNT-induced lung fibrosis and develop rapid in vitro screening assays which may be predictive of the in vivo fibrogenic response. Aim 2 will delineate key signaling pathways and fibrogenic factors involved in the induction of fibrosis by CNT in order to identify potential biomarkers and drug targets for diagnosis and treatment of the disease. Aim 3 will investigate the involvement of angiogenesis and angiogenic factors in the development of pulmonary fibrosis induced by CNT. Aim 4 will determine redox regulation of CNT-induced fibrogenesis and angiogenesis and elucidate the underlying mechanisms. Through this application, we expect to define key nanoparticle characteristics and a set of in vitro screening assays for evaluation of the potential fibrogenicity of nanoparticles in vivo. Such information will be important for safe use of nanotechnology. The proposed studies will also identify molecular targets for early detection and treatment of fibrotic lung diseases caused by nanomaterials. PUBLIC HEALTH RELEVANCE: Relevance to Public Health: Nanotechnology presents enormous opportunities to create new and better products for industrial applications and for diagnosis and treatment of diseases. However, the potential adverse health effects of nanomaterials are unclear since information is lacking that would allow prediction of the biological activity of these new materials. This project will address NIH goals and public health needs by 1) determining key physiochemical properties of nanomaterials that contribute to their pulmonary toxicity and fibrogenicity, 2) developing rapid screening assays for prediction of the fibrogenic effects of nanomaterials, and 3) elucidating the underlying mechanisms of pulmonary fibrosis induced by nanomaterials in order to identify specific biomarkers and drug targets for early diagnosis and treatment of the disease.
描述(由申请人提供): 项目摘要:在过去几年中,人造纳米材料的环境和职业接触显著增加,而且随着新纳米材料的生产和各行业的使用越来越多,这一趋势很可能会继续下去。这一趋势引起了极大的关注,因为纳米材料对健康的不利影响相对未知且研究不足。最近的研究表明,肺部暴露于碳纳米管(CNT),工业中最广泛使用的纳米材料之一,导致动物快速和进行性间质性肺纤维化,而不会引起持续性肺部炎症,这通常与其他已知的纤维化药物有关。CNT的这种不寻常的纤维化作用引起了重要的健康问题,因为暴露可能导致致命和不可治愈的肺纤维化。我们假设,CNT,由于其独特的性能,如非常小的尺寸,大的纵横比,和化学成分可以迅速进入肺,穿透肺泡上皮屏障,并与特定的肺细胞,如间质肺成纤维细胞相互作用,以诱导纤维增生和细胞外基质积累,这是肺纤维化的特征。我们还提出,这种诱导是由信号级联介导的,涉及磷脂酰肌醇-3-激酶(PI 3 K)/Akt激活和氧化还原调节促纤维化和血管生成因子,如TGF-β和VEGF。在目标1中,我们将确定某些纳米颗粒特性(例如,直径、纵横比、分散状态和化学)对CNT诱导的肺纤维化的影响,并开发可预测体内纤维化反应的快速体外筛选测定。目的2将描述CNT诱导纤维化的关键信号通路和纤维化因子,以确定诊断和治疗该疾病的潜在生物标志物和药物靶点。目的3探讨血管生成及血管生成因子在碳纳米管致肺纤维化中的作用。目的4研究CNT诱导的纤维化和血管生成的氧化还原调控机制,并阐明其机制。通过这一应用,我们期望定义关键的纳米颗粒特性和一组体外筛选试验,用于评估纳米颗粒在体内的潜在致纤维化性。这些信息对于安全使用纳米技术将是重要的。拟议的研究还将确定早期检测和治疗纳米材料引起的纤维化肺病的分子靶点。 公共卫生关系: 与公共卫生的相关性:纳米技术提供了巨大的机会,创造新的和更好的产品,用于工业应用和诊断和治疗疾病。然而,纳米材料对健康的潜在不利影响尚不清楚,因为缺乏能够预测这些新材料的生物活性的信息。该项目将通过以下方式解决NIH目标和公共卫生需求:1)确定纳米材料导致其肺毒性和纤维化的关键理化特性,2)开发快速筛选测定方法,用于预测纳米材料的纤维化效应,和3)阐明纳米材料诱导肺纤维化的潜在机制,以确定用于早期诊断的特定生物标志物和药物靶点,疾病的治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yon Rojanasakul其他文献

Yon Rojanasakul的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yon Rojanasakul', 18)}}的其他基金

Nanoparticle Fibrogenicity and Fibroblast Stem-Like Cells
纳米颗粒成纤维性和成纤维细胞样细胞
  • 批准号:
    9212809
  • 财政年份:
    2016
  • 资助金额:
    $ 36.75万
  • 项目类别:
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes
碳纳米管诱导肿瘤转化和癌症干细胞
  • 批准号:
    8846114
  • 财政年份:
    2014
  • 资助金额:
    $ 36.75万
  • 项目类别:
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes
碳纳米管诱导肿瘤转化和癌症干细胞
  • 批准号:
    8691555
  • 财政年份:
    2014
  • 资助金额:
    $ 36.75万
  • 项目类别:
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes
碳纳米管诱导肿瘤转化和癌症干细胞
  • 批准号:
    9024527
  • 财政年份:
    2014
  • 资助金额:
    $ 36.75万
  • 项目类别:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
碳纳米管诱导纤维化的预测及机制
  • 批准号:
    8268403
  • 财政年份:
    2010
  • 资助金额:
    $ 36.75万
  • 项目类别:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
碳纳米管诱导纤维化的预测及机制
  • 批准号:
    8463235
  • 财政年份:
    2010
  • 资助金额:
    $ 36.75万
  • 项目类别:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
碳纳米管诱导纤维化的预测及机制
  • 批准号:
    8111227
  • 财政年份:
    2010
  • 资助金额:
    $ 36.75万
  • 项目类别:
Regulation of Fas-Mediated Lung Cell Apoptosis
Fas 介导的肺细胞凋亡的调节
  • 批准号:
    7838821
  • 财政年份:
    2009
  • 资助金额:
    $ 36.75万
  • 项目类别:
Regulation of Fas-Mediated Lung Cell Apoptosis
Fas 介导的肺细胞凋亡的调节
  • 批准号:
    7100360
  • 财政年份:
    2006
  • 资助金额:
    $ 36.75万
  • 项目类别:
Regulation of Fas-Mediated Lung Cell Apoptosis
Fas 介导的肺细胞凋亡的调节
  • 批准号:
    7579060
  • 财政年份:
    2006
  • 资助金额:
    $ 36.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了